Agilent Technologies, Inc. (NYSE:A) is Impax Asset Management Group plc's 9th Largest Position

Impax Asset Management Group plc increased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 3.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,931,794 shares of the medical research company's stock after buying an additional 102,365 shares during the period. Agilent Technologies comprises approximately 2.1% of Impax Asset Management Group plc's holdings, making the stock its 9th largest holding. Impax Asset Management Group plc owned about 1.03% of Agilent Technologies worth $342,961,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in A. Pacific Heights Asset Management LLC grew its stake in Agilent Technologies by 1.6% in the first quarter. Pacific Heights Asset Management LLC now owns 65,000 shares of the medical research company's stock valued at $7,604,000 after purchasing an additional 1,000 shares during the last quarter. IFM Investors Pty Ltd grew its stake in Agilent Technologies by 10.3% in the first quarter. IFM Investors Pty Ltd now owns 60,659 shares of the medical research company's stock valued at $7,096,000 after purchasing an additional 5,659 shares during the last quarter. OneDigital Investment Advisors LLC grew its stake in Agilent Technologies by 11.6% in the first quarter. OneDigital Investment Advisors LLC now owns 7,506 shares of the medical research company's stock valued at $878,000 after purchasing an additional 778 shares during the last quarter. Calamos Advisors LLC grew its stake in Agilent Technologies by 1.1% in the first quarter. Calamos Advisors LLC now owns 170,212 shares of the medical research company's stock valued at $19,911,000 after purchasing an additional 1,896 shares during the last quarter. Finally, D.A. Davidson & CO. grew its stake in Agilent Technologies by 30.4% in the first quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company's stock valued at $1,108,000 after purchasing an additional 2,207 shares during the last quarter.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock traded up $0.50 during trading hours on Friday, reaching $121.16. 944,958 shares of the company's stock were exchanged, compared to its average volume of 1,846,516. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company has a market capitalization of $34.42 billion, a P/E ratio of 29.91, a price-to-earnings-growth ratio of 3.68 and a beta of 1.23. The business has a fifty day moving average of $113.79 and a two-hundred day moving average of $123.21. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. During the same quarter in the prior year, the firm earned $1.22 earnings per share. The company's revenue for the quarter was up 6.0% compared to the same quarter last year. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies's dividend payout ratio is currently 24.44%.

Analysts Set New Price Targets

A has been the topic of several analyst reports. Jefferies Financial Group cut their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Wells Fargo & Company cut their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Robert W. Baird dropped their price target on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research note on Thursday, May 22nd. UBS Group dropped their price target on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research note on Thursday, May 29th. Finally, Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $140.92.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.